Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy
This study has been completed.
Sponsored by: S.L.A. Pharma AG
Information provided by: S.L.A. Pharma AG
ClinicalTrials.gov Identifier: NCT00774722
  Purpose

The purpose of this study is to determine whether metronidazole 10% ointment , applied topically three times a day in and around the anus, on the reduction of pain following haemorrhoidectomy.


Condition Intervention Phase
Haemorrhoidectomy
Drug: Metronidazole
Phase II
Phase III

Drug Information available for: Metronidazole Metronidazole hydrochloride Metronidazole phosphate
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Parallel Assignment
Official Title: Phase 2 Study Evaluation of Topical 10% Metronidazole Ointment for the Reduction of Pain After Haemorrhoidectomy

Further study details as provided by S.L.A. Pharma AG:

Primary Outcome Measures:
  • The primary objective is to evaluate the efficacy of 10% metronidazole ointment in reducing post-operative pain associated with haemorrhoidectomy as compared to placebo. [ Time Frame: 14 days ]

Secondary Outcome Measures:
  • evaluate and compare the expected pain following haemorrhoidectomy in the treatment and placebo groups. overall patient satisfaction with the operation. the number of analgesics required post-operatively the time taken to return to work and/or [ Time Frame: 56 days ]

Estimated Enrollment: 40
Study Start Date: September 2006
Study Completion Date: March 2008
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Metronidazole
    10% ointment, three times daily for 14 days
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Have Grade 3 or 4 haemorrhoids (external disease with or without significant internal component)
  • Be scheduled for diathermy haemorroidectomy with ≥2 quadrant involvement
  • Be medically fit for surgery
  • Subjects must be aged 18 years or over and of the legal age of consent.
  • If female, the subject must not be lactating and must be (a) post-menopausal, (b) surgically sterilised, or (c) have a negative pregnancy test result prior to entry into the study and will use adequate contraception for the duration of the study.
  • Must have provided written informed consent to participate.

Exclusion Criteria:

  • They have had surgery to the anus or rectum in the past 8 weeks
  • Suffer from a chronic pain syndrome which requires regular narcotic analgesia
  • Have anal fissures
  • Have diagnosed Crohn's disease
  • Allergic to metronidazole
  • Are taking any prohibited medication.
  • Deemed mentally incompetent
  • Considered by their physician unlikely to be able to comply with the protocol.
  • Taken part in an experimental drug study in the preceding three months.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00774722

Locations
United Kingdom
St Thomas' Hospital, Lambeth Palace Road
London, United Kingdom, SE1 7EH
Royal Sussex County Hospital, Eastern Road,
Brighton, United Kingdom, BN2 5BE
North Middlesex University Hospital
London, United Kingdom, N18 1QX
Stepping Hill Hospital
Stockport, United Kingdom, SK2 7JE
St Marks Hospital
Harrow, United Kingdom, HA1 3UJ
Sponsors and Collaborators
S.L.A. Pharma AG
Investigators
Study Director: Christopher J Jordan, BSc SLA Pharma
  More Information

Study ID Numbers: MET/02, EudraCT Number 2005-001396-35
Study First Received: October 16, 2008
Last Updated: October 16, 2008
ClinicalTrials.gov Identifier: NCT00774722  
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

Study placed in the following topic categories:
Metronidazole
Pain

Additional relevant MeSH terms:
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Radiation-Sensitizing Agents
Therapeutic Uses
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 16, 2009